Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by amendison Dec 30, 2014 7:06pm

198 Views

Post# 23273907

Geting better and beter every puar

Microbix Biosystems Inc closed up sharply Monday, rallying $0.08 or 12.12% to $0.74. Over the last five days, shares have gained 8.82% and 348.48% year to date. Shares have outperformed the S&P TSX by 385.42% during the last year. something to enjoy for long

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price